1269626-27-8Relevant articles and documents
Heterocyclic pyridine-pyrimidinone derivative as CDK (Cyclin-Dependent Kinase) inhibitor and application thereof
-
Paragraph 0041; 0043, (2017/11/04)
The invention relates to a heterocyclic pyridine-pyrimidinone derivative and application of the heterocyclic pyridine-pyrimidinone derivative used as a therapeutically effective CDK (Cyclin-Dependent Kinase) inhibitor, and in particular to application of a novel heterocyclic pyridine-pyrimidinone derivative as shown in a general formula (I) and a pharmaceutical composition thereof which are used as selective CDK4/6 inhibitors in preventing or treating diseases related to CDK4/6.